ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $889,548 | +66.2% | 248,477 | +71.3% | 0.00% | +100.0% |
| Q2 2023 | $535,098 | +2.6% | 145,013 | -8.0% | 0.00% | 0.0% |
| Q1 2023 | $521,583 | -17.4% | 157,578 | -3.1% | 0.00% | 0.0% |
| Q4 2022 | $631,264 | +76.8% | 162,697 | +10.7% | 0.00% | 0.0% |
| Q3 2022 | $357,000 | -25.0% | 147,034 | -38.9% | 0.00% | 0.0% |
| Q2 2022 | $476,000 | +93.5% | 240,611 | +79.0% | 0.00% | – |
| Q1 2022 | $246,000 | +29.5% | 134,425 | -0.4% | 0.00% | – |
| Q4 2021 | $190,000 | +54.5% | 134,949 | +23.8% | 0.00% | – |
| Q3 2021 | $123,000 | +2.5% | 109,037 | +45.5% | 0.00% | – |
| Q2 2021 | $120,000 | -9.8% | 74,957 | -0.6% | 0.00% | – |
| Q1 2021 | $133,000 | +66.2% | 75,410 | +83.9% | 0.00% | – |
| Q4 2020 | $80,000 | -15.8% | 41,002 | +3.0% | 0.00% | – |
| Q3 2020 | $95,000 | -22.1% | 39,800 | -4.6% | 0.00% | – |
| Q2 2020 | $122,000 | -17.0% | 41,725 | +76.1% | 0.00% | -100.0% |
| Q3 2018 | $147,000 | +119.4% | 23,700 | +59.1% | 0.00% | – |
| Q2 2018 | $67,000 | – | 14,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |